CARLSBAD, Calif.--(BUSINESS WIRE)--The Immune Response Corporation (OTCBB: IMNR), an immuno-pharmaceutical company focused on developing products to treat autoimmune and infectious diseases, announced that Dr. Joseph O’Neill, President and CEO, will present an overview of the Company’s immune-based therapies, currently in Phase II clinical trials, at the Rodman & Renshaw Eighth Annual Healthcare Conference in New York City.
